Aging and 3,4-diaminopyridine alter synaptosomal calcium uptake

Area of Science:

• Neuroscience
• Gerontology
• Cellular Biology

Background:

• Cognitive decline is a hallmark of aging, but its molecular underpinnings remain unclear.
• Evidence suggests senescence may disrupt calcium homeostasis, a critical process for neuronal function.

Purpose of the Study:

• To investigate the impact of aging on calcium uptake in rat brain synaptosomes.
• To explore the potential of 3,4-Diaminopyridine in modulating age-related changes in calcium handling.

Main Methods:

• Calcium influx was measured in synaptosomes from rats of varying ages (3, 6, 15, and 27 months) under different potassium concentrations.
• The effect of 3,4-Diaminopyridine on potassium-stimulated calcium influx and superficial calcium binding was assessed.

Main Results:

• Aging significantly reduced calcium uptake in synaptosomes, particularly at later ages.
• 3,4-Diaminopyridine dose-dependently increased potassium-stimulated calcium influx and reduced superficial calcium binding in aged rats.
• Superficial calcium binding increased with age, but was partially reversed by 3,4-Diaminopyridine.

Conclusions:

• Age-related decline in synaptosomal calcium uptake may contribute to cognitive impairment.
• Modulating calcium homeostasis with agents like 3,4-Diaminopyridine could offer therapeutic potential for age-related cognitive dysfunction.